When it gets to 10 US we will be there. Right now it has not gotten to its pre-reverse split level.
I don't know but PTN stock price is in the toilet. Is there a problem with the phase III clinical trial of the eye ointment?
I hadn’t considered management getting paid to stifle Vyleesi as a possibility. That would be fraud against PTN shareholders. It wouldn’t take much money perhaps to pay off an executive compared to the billions in profits from Viagra, Cialis and other meds.
I took bremelanotide two years ago bought from the UK (for research only) and went to a high quality strip club and did notice an increased level of visual excitement, arousal and desire regarding the topless young dancing ladies. It seems to work remarkably well for me.
Transdermal patch technology could be an ideal route of administration. The next best thing would be a nasal spray or dropper. I do think that men is the true market for this drug. Men must achieve a long lasting hard erection. Women do not have that level of performance execution requirement.
The $1000 a month price tag is too high for the general public to access this valuable med. Perhaps other countries could take this drug and make it available at a reasonable price.
$20 to $30 per dose would be reasonable in my mind.
You are exactly right. Men should not be denied however the idea was to market to women...where there was not any competition, then of course husbands and boyfriends would use it too...even more than women. The lousy marketing efforts by the contracted sales company was so pitiful... i think on purpose. The company itself could have done a better job by employing a sales force. It is a no brainer sale....but the price was so high to make it effectively out of reach for the majority of people. This CEO is the poorest I have ever seen. First of all they basically stole the drug from Australia anyway.
It was marketed on the black market, you could buy it in England and other places. It works .... so well ..... it is actually a game changer for men especially.
I have never seen a better product stifled by mismanagement. I do believe the company is being paid... or has been paid to keep it off the market to any large degree. All the while the insiders rake in their salary too.
I fully expect if this continues to see the company go under or go private which will be what happens IMO either through a merger, buyout, or bankruptcy. Keeping erect for 80 minutes is more than a gold mine.
The market cap is $60 million. I think I saw recently that PTN has $60 million left from what AMAG gave to PTN to drop Vyleesi.
A valuation of a company at cash on hand should be some sort of floor fundamentally.
In the short term stocks are a popularity contest. Reverse stock splits are unpopular. In the long term stock valuation is a weighing process.
The DED treatment could actually work.
Vyleesi is FDA approved and works better in men than in women. Women are not a good market for an aphrodisiac but men would be a strong market.
It is hard I understand however to believe in a company that has never delivered for its shareholders in the past.
Vyleesi aka PTN-141 aka bremelanotide is in fact an effective aphrodisiac. Somehow this fact just got buried. This is counterintuitive. The drug works, but the company failed to market the drug effectively.
The DED treatment uses a novel mechanism of action. It could be more effective than the SOC. Phase 3 with finish fairly soon.
Informing the shareholder is not a high priority with the PTN management. Vyleesi could get discovered by women and shared with husbands and other partners. Men benefit even more than do women on average. This never gets discussed. Why should men be denied?
Sales increase 225% last quarter and the stock sits at a 5 year low. Fu cking scum sucking management....Give back to your shareholders for once.
Could it be the Dry Eye treatment that has sparked an interest here? There is also an IBD treatment in trials? Vyleesi also works in men which would be a large market. A Vyleesi patch if possible would avoid the needle that limits demand for this sort of nonessential product.
Sitting at .76......patiently waiting